Conflict of interest is a situation not a behaviour and is impossible to completely avoid. In the interests of openness the list below details recent potential conflicts, more details are available on request.
Employment by Bloomfield Medical (an NHS General Practice).
Employment by Lancashire and South Cumbria ICB.
Employment by NHS England.
Superintendent Pharmacist for FCMS (NW) Ltd (an alternative provider of medical services, including GP OOH and UTCs).
Occasional sessional work for FCMS.
Occasional contracts with or sessions for universities and other organisations e.g. LJMU, UCLAN, NICE, CPPE, RCGP, NHS bodies.
Occasional writing commissions or payment for articles from a number of publications.
Membership of and involvement with various professional bodies.
I have received payment from the following pharmaceutical companies since 2010:
Astellas: 1 presentation in 2010.
Lilly: 1 presentation in 2011.
Pfizer: 1 focus group in 2011.
Chiesi: 2 presentations in 2013, 5 in 2014, 6 in 2015, 2 in 2016, 3 in 2017, 3 in 2018, 4 in 2021, 7 in 2022, and 3 in 2023.
AstraZeneca: 1 presentation in 2016 and 1 in 2017.
I have been supported by funding from GSK and AstraZeneca to undertake diplomas in Asthma and COPD with Respiratory Education UK in 2009/2010.
I occasionally receive hospitality (e.g. lunches) and small items (e.g. reference books) from various pharmaceutical companies in the context of educational meetings.
I received a funded place (including accommodation and meals) at the Primary Care Respiratory Society conference in 2022 from Chiesi.
The practice where I am employed has received grants for various educational activities/development projects from Boehringer Ingelheim (2017), Pfizer (2018), and Chiesi (2024).
I do not own shares in healthcare related companies (except this one!), including the pharmaceutical industry (although it is possible that the investment funds within my pension invest in these companies).
I have a preserved pension with Boots the Chemists.